How low blood protein affects bleeding risk from an IV antibiotic after surgery
Part of Blood & lymphatic, Infections clinical trials.
This study looks at whether having low blood protein (called albumin) increases the risk of bleeding problems in people who are taking a certain IV antibiotic after surgery. The goal is to understand this risk so doctors can monitor patients better and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have had surgery and be recovering in the hospital
- You must be receiving an IV antibiotic called cefoperazone/sulbactam for at least 3 days
- You cannot have chronic liver disease or a bleeding disorder
- You cannot be taking blood thinners or have had major blood loss requiring a transfusion
- You cannot be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a protein in the blood) along with standard fluids helps patients with septic shock after a surgical infection. The goal is to see if it improves recovery and survival compared to fluids alone.
This study tests if giving the sedative ciprofol in carefully adjusted doses can prevent low blood pressure during and after laparoscopic belly surgery in older adults. It may help your surgical team keep your blood pressure stable.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This study measures how antibiotics work in patients who have had a massive blood transfusion. It aims to ensure the right dose of common antibiotics is being given.
This study compares a new way of delivering antibiotics directly into the bone during hip replacement surgery versus the standard IV method. The goal is to see if this approach prevents infection just as well while potentially improving outcomes.
Hear when a new Cefoperazone/Sulbactam Induced Coagulopayjy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.